Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Reid Laurence bought 20,000 Metagenomi Therapeutics, Inc. shares (Form 4)
Traded Sep 9, 2026 · Filed Sep 11, 2026
On Sep 9, 2026, Reid Laurence (Director) bought 20,000 Metagenomi Therapeutics, Inc. shares at an average US$1.17 for US$23,401, leaving 20,000 shares. Filed Sep 11, 2026 (Form 4).
- Bought
- 20,000 shares
- Price
- US$1.17 average (US$1.17 to US$1.18)
- Value
- US$23,401
- Holding after
- 20,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Common Stock | Buy | 19,883 | US$1.17 | 19,883 | Direct |
| Sep 9, 2026 | Common Stock | Buy | 117 | US$1.18 | 20,000 | Direct |